Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Or Offer | SMWB Similarweb Ltd. | 13G/A | 8.27% | Dec 31, 2023 | 2y |
| Medtronic plc | OBIO Orchestra BioMed Holdings, Inc. | 13G/A | 16.4% | Dec 31, 2023 | 2y |
| Alta Fundamental Advisers LLC | TDAY USA TODAY Co., Inc. | 13G/A | 8.8% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | AKR Acadia Realty Trust | 13G/A | 8.9% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | TW Tradeweb Markets Inc. | 13G | 6.5% | Dec 31, 2023 | 2y |
| LCG Holdings, LLC | FPH Five Point Holdings, LLC | 13G/A | 15.3% | Dec 31, 2023 | 2y |
| Clal Insurance Enterprises Holdings Ltd | PGY Pagaya Technologies Ltd. | 13G/A | 3.6% | Dec 31, 2023 | 2y |
| Silver Point Capital L.P. | MSC STUDIO CITY INTERNATIONAL HOLDINGS Ltd | 13G/A | 14.9% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | STRA Strategic Education, Inc. | 13G/A | 12.7% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | SHYF The Shyft Group, Inc. Common Stock | 13G/A | 6.3% | Dec 31, 2023 | 2y |
| Berkshire Hathaway Inc | KHC Kraft Heinz Co | 13G/A | 26.5% | Dec 31, 2023 | 2y |
| Paul Packer | FKWL Franklin Wireless Corp | 13G/A | 8.9% | Dec 31, 2023 | 2y |
| Condire Management, LP | RYAM Rayonier Advanced Materials Inc. | 13G/A | 9.73% | Dec 31, 2023 | 2y |
| First Light Asset Management, LLC | SONX Sonendo, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| NOMURA HOLDINGS INC | CRLBF Cresco Labs Inc. | 13G | 7.6% | Dec 31, 2023 | 2y |
| Redmile Group, LLC | FOLD AMICUS THERAPEUTICS, INC. | 13G/A | 7.3% | Dec 31, 2023 | 2y |
| Nuveen Asset Management, LLC | ARCO Arcos Dorados Holdings Inc. | 13G/A | 6.74% | Dec 31, 2023 | 2y |
| Westchester Capital Management, LLC | WELNF Integrated Wellness Acquisition Corp | 13G | 9.94% | Dec 31, 2023 | 2y |
| Leon Recanati | KMDA Kamada Ltd | 13G/A | 6.15% | Dec 31, 2023 | 2y |
| GATES MELINDA FRENCH | CNI Canadian National Railway Co | 13G/A | 10.1% | Dec 31, 2023 | 2y |
| Index Venture Associates VI Ltd | HOOD Robinhood Markets, Inc. | 13G/A | 6.9% | Dec 31, 2023 | 2y |
| BROWN CAPITAL MANAGEMENT LLC | GKOS GLAUKOS Corp | 13G/A | 5.53% | Dec 31, 2023 | 2y |
| Southpoint Capital Advisors LP | TNGX Tango Therapeutics, Inc. | 13G/A | 5.2% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | CAG Conagra Brands Inc. | 13G | 5.1% | Dec 31, 2023 | 2y |
| Sandia Investment Management LP | VCXB 10X Capital Venture Acquisition Corp. III | 13G/A | 0.76% | Dec 31, 2023 | 2y |
| Biglari Holdings Inc. | JACK Jack In The Box Inc | 13G/A | 5.8% | Dec 31, 2023 | 2y |
| Omega Fund VII, L.P. | ENGN enGene Therapeutics Inc. | 13G | 6.8% | Dec 31, 2023 | 2y |
| AQR CAPITAL MANAGEMENT LLC | ELIQ Electriq Power Holdings, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | TNYA Tenaya Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Aristotle Capital Boston, LLC | FLWS 1 800 Flowers Com Inc | 13G/A | 5.68% | Dec 31, 2023 | 2y |
| VIKING GLOBAL INVESTORS LP | ADPT Adaptive Biotechnologies Corp | 13G/A | 20.7% | Dec 31, 2023 | 2y |
| ANNE E. GITTINGER | JWN Nordstrom, Inc. | 13G/A | 9.49% | Dec 31, 2023 | 2y |
| Joseph A. Walsh | THRY Thryv Holdings, Inc. | 13G/A | 8.45% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | CNTM ConnectM Technology Solutions, Inc. | 13G | 9.28% | Dec 31, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | EOLS Evolus, Inc. | 13G/A | 6.9% | Dec 31, 2023 | 2y |
| Curtis D. Hodgson | LEGH Legacy Housing Corp | 13G/A | 19.1% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | MX MAGNACHIP SEMICONDUCTOR Corp | 13G/A | 5.9% | Dec 31, 2023 | 2y |
| Andrew M. Brown Family Protection Trust | KSCP Knightscope, Inc. | 13G/A | 3.79% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | BECN Beacon Roofing Supply, Inc. | 13G | 5.4% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | PTGX Protagonist Therapeutics, Inc | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Double Sun Capital Limited | SFWL SHENGFENG DEVELOPMENT Ltd | 13G | 9.7% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | CVII Churchill Capital Corp VII Class A Common Stock | 13G | 9.58% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners II, L.P. | DBVT DBV Technologies S.A. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| NOMURA HOLDINGS INC | CRMD CorMedix Inc. | 13G/A | 5.4% | Dec 31, 2023 | 2y |
| EcoR1 Capital, LLC | APLS Apellis Pharmaceuticals, Inc. | 13G/A | 9.4% | Dec 31, 2023 | 2y |
| Fort Baker Capital Management LP | SOC Sable Offshore Corp. | 13G/A | 5.16% | Dec 31, 2023 | 2y |
| M3 Funds, LLC | HMNF HMN Financial Inc | 13G/A | 7.38% | Dec 31, 2023 | 2y |
| Cormorant Asset Management, LP | ELEV Elevation Oncology, Inc. Common stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | PDLB Ponce Financial Group, Inc. | 13G/A | 10.6% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | MCAA Mountain & Co. I Acquisition Corp. Class A Ordinary Shares | 13G/A | 4.43% | Dec 31, 2023 | 2y |